Exchange: NASDAQ·Updated 07:58 PM EDT
HOWL logo

HOWL Werewolf Therapeutics Inc

$0.9433
$0.0275
(2.83%)
Today
Closed $0.9433
$0.0182
(1.93%)
After Hours
Reported EarningsJul 31
Mkt Cap$45.84M
Vol2.33M

About HOWL

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.
52

Neutral Sentiment

How do you feel about HOWL?

Advertisement|Remove ads.